Endpoints News 生物医药· Max Gelman·· 23 天前AI 评分23
关键 III 期数据读出前,分析师追问 Biogen 狼疮药 litifilimab
Analysts press Biogen on lupus drug litifilimab ahead of pivotal readouts
AI 导读
在多项 III 期关键数据读出前,分析师就 Biogen 狼疮药物 litifilimab 向公司提出多项问题;该后期管线被视为 CEO Chris Viehbacher 转型计划的关键。具体 III 期结果尚未公布。
正文
Scrutiny of Biogen’s late-stage pipeline is intensifying ahead of several Phase 3 readouts that are pivotal to CEO Chris Viehbacher’s turnaround efforts.
Analysts lobbed numerous …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news